Modulation of GDP Release from Transducin by the Conserved Glu134-Arg135 Sequence in Rhodopsin*

A superfamily of seven-transmembrane helix receptors catalyzes GDP release from heterotrimeric guanine nucleotide-binding proteins (G proteins) to initiate the intracellular signaling cascade. The photoreceptor rhodopsin is a prototypical member of the superfamily that activates the retinal G protein transducin (Gt). The cytoplasmic domain of rhodopsin binds and activates Gt, but residues that stimulate GDP release from Gt have not been identified until now. We show here that the abnormal signal transduction phenotypes of several different mutations affecting the highly conserved Glu134-Arg135 charge pair result from alteration of the GDP release step in the Gt activation cascade. We propose that Glu134 and Arg135 constitute the site that directly provides the signal from rhodopsin to activate GDP release from Gt. Because the Glu/Asp−Arg sequence occurs at a topologically identical location in most of the seven-transmembrane helix receptors, we propose that these residues constitute a switch for signal transfer.

[1]  H. Khorana,et al.  Mapping light-dependent structural changes in the cytoplasmic loop connecting helices C and D in rhodopsin: a site-directed spin labeling study. , 1995, Biochemistry.

[2]  H. Hamm,et al.  NMR structure of a receptor-bound G-protein peptide , 1993, Nature.

[3]  T. Sakmar,et al.  Characterization of Rhodopsin Mutants That Bind Transducin but Fail to Induce GTP Nucleotide Uptake , 1995, The Journal of Biological Chemistry.

[4]  H. Khorana,et al.  Total synthesis of a gene for bovine rhodopsin. , 1986, Proceedings of the National Academy of Sciences of the United States of America.

[5]  J. Thorner,et al.  Model systems for the study of seven-transmembrane-segment receptors. , 1991, Annual review of biochemistry.

[6]  J. Venter,et al.  Site-directed mutagenesis of m1 muscarinic acetylcholine receptors: conserved aspartic acids play important roles in receptor function. , 1989, Molecular pharmacology.

[7]  Bruce R. Conklin,et al.  Structural elements of Gα subunits that interact with Gβγ, receptors, and effectors , 1993, Cell.

[8]  Frank McCormick,et al.  The GTPase superfamily: a conserved switch for diverse cell functions , 1990, Nature.

[9]  A. Gilman.  G proteins and dual control of adenylate cyclase , 1984, Cell.

[10]  H. Khorana,et al.  Structure and function in rhodopsin. Studies of the interaction between the rhodopsin cytoplasmic domain and transducin. , 1992, The Journal of biological chemistry.

[11]  C. M. Davenport,et al.  Rhodopsin mutations responsible for autosomal dominant retinitis pigmentosa. Clustering of functional classes along the polypeptide chain. , 1993, The Journal of biological chemistry.

[12]  H. Khorana,et al.  Rhodopsin mutants that bind but fail to activate transducin. , 1990, Science.

[13]  P. Hargrave,et al.  Light-induced binding of guanosinetriphosphatase to bovine photoreceptor membranes: effect of limited proteolysis of the membranes. , 1981, Biochemistry.

[14]  K. Fahmy,et al.  Regulation of the rhodopsin-transducin interaction by a highly conserved carboxylic acid group. , 1993, Biochemistry.

[15]  S. Kaushal,et al.  Structure and function in rhodopsin. 7. Point mutations associated with autosomal dominant retinitis pigmentosa. , 1994, Biochemistry.

[16]  G. Johnson,et al.  Antipeptide antibodies directed against cytoplasmic rhodopsin sequences recognize the beta-adrenergic receptor. , 1987, The Journal of biological chemistry.

[17]  K. Fahmy,et al.  A conserved carboxylic acid group mediates light-dependent proton uptake and signaling by rhodopsin. , 1994, The Journal of biological chemistry.

[18]  L. Stryer,et al.  Flow of information in the light-triggered cyclic nucleotide cascade of vision. , 1981, Proceedings of the National Academy of Sciences of the United States of America.

[19]  M. Caron,et al.  Site-directed mutagenesis of the cytoplasmic domains of the human beta 2-adrenergic receptor. Localization of regions involved in G protein-receptor coupling. , 1988, The Journal of biological chemistry.

[20]  H. Khorana,et al.  Expression of a synthetic bovine rhodopsin gene in monkey kidney cells. , 1987, Proceedings of the National Academy of Sciences of the United States of America.

[21]  L. Stryer,et al.  Cyclic GMP cascade of vision. , 1986, Annual review of neuroscience.

[22]  J. Baldwin.  The probable arrangement of the helices in G protein‐coupled receptors. , 1993, The EMBO journal.

[23]  C. Fraser,et al.  Site-directed mutagenesis of alpha 2A-adrenergic receptors: identification of amino acids involved in ligand binding and receptor activation by agonists. , 1991, Molecular pharmacology.

[24]  H. Hamm,et al.  Site of G protein binding to rhodopsin mapped with synthetic peptides from the alpha subunit. , 1988, Science.

[25]  T. Sakmar,et al.  Characterization of mutant rhodopsins responsible for autosomal dominant retinitis pigmentosa. Mutations on the cytoplasmic surface affect transducin activation. , 1993, The Journal of biological chemistry.

[26]  P. Hargrave,et al.  Three cytoplasmic loops of rhodopsin interact with transducin. , 1989, Proceedings of the National Academy of Sciences of the United States of America.

[27]  H. Khorana,et al.  Cysteine residues 110 and 187 are essential for the formation of correct structure in bovine rhodopsin. , 1988, Proceedings of the National Academy of Sciences of the United States of America.

[28]  D. Oprian,et al.  Constitutive activation of opsin: influence of charge at position 134 and size at position 296. , 1993, Biochemistry.

[29]  E. El-Fakahany,et al.  An arginine residue conserved in most G protein-coupled receptors is essential for the function of the m1 muscarinic receptor. , 1994, Molecular pharmacology.

[30]  R. A. Morton,et al.  Studies on rhodopsin. IX. pH and the hydrolysis of indicator yellow. , 1955, The Biochemical journal.